Fresenius Medical Care AG (FMCQF) Receivables - Other (2009 - 2026)

Fresenius Medical Care AG has reported Receivables - Other for 18 years, with the latest figure at $34.4 million in Q2 2026.

• On a quarterly basis, Receivables - Other fell 15.22% year-over-year to $34.4 million in Q2 2026; TTM through Jun 2026 was $34.4 million, a 15.22% decrease from a year earlier, with the FY2025 full-year figure at $38.0 million, down 13.03% from the prior year.
• Receivables - Other was $34.4 million for Q2 2026 at Fresenius Medical Care AG, roughly flat from $34.5 million in the prior quarter.
• The five-year high for Receivables - Other was $205.8 million in Q1 2022, with the low at $28.4 million in Q1 2025.
• Average Receivables - Other over 5 years is $99.3 million, with a median of $96.4 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 46.93% in 2024, then slumped 77.52% in 2025.
• Over 5 years, Receivables - Other stood at $142.9 million in 2022, then rose by 24.45% to $177.9 million in 2023, then slumped by 75.4% to $43.7 million in 2024, then fell by 13.03% to $38.0 million in 2025, then fell by 9.66% to $34.4 million in 2026.
• The last three Receivables - Other figures came in at $34.4 million (Q2 2026), $34.5 million (Q1 2026), and $38.0 million (Q4 2025), per Business Quant data.